Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Graft vs Host Disease × Idarubicin × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 36 Leukemia 15 Congenital Abnormalities 9 Leukemia, Monocytic, Acute 8 Leukemia, Myelomonocytic, Acute 7 Leukemia, Megakaryoblastic, Acute 6 Leukemia, Erythroblastic, Acute 6 Myelodysplastic Syndromes 5 Recurrence 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Leukemia, Eosinophilic, Acute 3 Anemia, Refractory, with Excess of Blasts 3 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Basophilic, Acute 2 Neoplasms 1 Myeloproliferative Disorders 1 Liver Neoplasms 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Biphenotypic, Acute 1 Childhood Acute Promyelocytic Leukemia With PML-RARA 1

Interventions

Tacrolimus 23 Cyclophosphamide 18 Methotrexate 17 fludarabine phosphate 16 Mycophenolic Acid 13 Busulfan 13 Antilymphocyte Serum 13 fludarabine 10 Whole-Body Irradiation 10 Sirolimus 9 thymoglobulin 8 Peripheral Blood Stem Cell Transplantation 7 Cyclosporine 7 Hematopoietic Stem Cell Transplantation 5 Filgrastim 5 Radiotherapy 4 Pentostatin 4 Methylprednisolone 4 Melphalan 4 Cyclosporins 4 Thiotepa 3 Stem Cell Transplantation 3 Rituximab 3 Granulocyte Colony-Stimulating Factor 3 Flow Cytometry 3 Etoposide 3 ruxolitinib 2 merphos 2 Vorinostat 2 Therapeutics 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡